'FEBS Communications' posts general items from the FEBS Network Team as well as news on FEBS events and other activities.

I'm a PhD student currently studying aging with repurposed drugs. My model organism of interest is C. elegans.   I am deep-diving into topics of proteostasis, aging and drug repurposing.  Connect with me to explore more of these topics. 

MSc in Bacterial Physiology and PhD in Protein Biochemistry Professor (Associate) at Akdeniz University Structural and functional analysis of rat prolactin receptor gene. Rat prolactin receptor and isoforms in liver and kidney. Non-genotoxic toxicity and tumorigenesis mechanisms of ochratoxin A (OTA) in vivo and in vitro. The role of testosterone and estrogen in OTA toxicity. The receptor mediated OTA toxicity and tumorigenesis in rat kidney. Ochratoxins Prolactin Receptors Estrogen Antagonists Estrogen Receptor Testosterone Androgen Receptors Nonsteroidal Anti-Androgens Ovariectomy Castration mRNA Expression Renal Pathology Renal Cancer Targeted Drug Delivery Toxicity Endocrine Disruption Reproductive Toxicology Estrogens Cancer Biology Androgens Steroids Toxicity Studies Native PAGE Endocrine Disruptors Environmental Toxicology Animal Physiology Encapsulation Cancer Research Nanoparticles Microbiology Biotechnology Proteins Protein Stability Ions Mycotoxins Cancer Cell Biology Fluorescence Spectroscopy Site-Directed Mutagenesis Wistar Rats Protein Folding Circular Dichroism Protein Conformation Cell Culture Molecular Endocrinology Neuroendocrinology Biomarkers PCR Protein Purification Reproductive Endocrinology Protein Structure Protein-Protein Interaction

The FEBS Junior Section is organised by students and young researchers from some FEBS Constituent Societies. They develop joint activities, such as online talks and other events, and share resources, as well as open doors for young European scientists to opportunities outside their home countries by providing the relevant contacts and fostering communication within the network.

Subham Preetam is the Founder & CEO of N BASE. He is a professional biotechnologist in the field of biorobotics, cancer, immunity, biomedical, and nanometerial research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals. With extensive cross-disciplinary training and experience in translational research, he is currently focused on various research topics, including microrobotics, soft bio-hybrid robots, and quantum nanoparticles for drug delivery. Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer.